Plasma ascorbate and vitamin E levels in Hong Kong Chinese

European Journal of Clinical Nutrition

Volumn 52, Issue 6, 1998, Pages 447-451

  Benzie, I F F ^a   Janus, E D ^b   Strain, J J ^c  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Age; Alpha tocopherol; Ascorbate; CHD risk; Chinese; Diet; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; FEMALE; HONG KONG; HUMAN; MALE; NORMAL HUMAN; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0031799154     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600586     Document Type: Article

References (45)

1. Alaimo K, McDowell MA, Briefel RR, Bischof AM, Caughman CR, Loria CM & Johnson CL (1994): Dietary intake of vitamins, minerals, and fibre of persons aged 2 months and over in the United States. Third National Health and Nutrition Examination Survey, Phase I, 1988-91. Advance Data #258, US Department of Health and Human Services, CDC.
2. Bates CJ (1997): Bioavailability of vitamin C. Eur. J. Clin. Nutr. 51, S28-S33.
3. Bellizzi MC, Franklin MF, Duthie GG & James WPT (1994): Vitamin E and coronary heart disease: the European paradox. Eur. J. Clin. Nutr. 48, 822-831.
4. Benzie IFF (1996a): Lipid peroxidation: a review of causes consequences measurement and dietary influences. Int. J. Food Sci. Nutr. 47, 233-262.
5. Benzie IFF (1996b). An automated, specific, spectrophotometric method for measuring ascorbic acid in plasma (EFTSA). Clin. Biochem. 29, 111-116.
6. Benzie IFF & Strain JJ (1996): Uric acid - friend or foe? Redox Report 2, 231-234.
7. Benzie IFF & Strain JJ (1997): Acute post-ingestion changes in plasma ascorbic acid concentration: relationship to dose and to existing body stores. Nutr. Res. 17, 187-190.
8. Block G, Patterson, B & Subar A (1992): Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 18, 1-29.
9. Bowry VW, Mohr D, Cleary J & Stocker R (1995): Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270, 5756-5763.
10. Berliner JA & Heinecke JW (1996): The role of oxidised lipoproteins in atherogenesis. Free Rad. Biol. Med. 20, 707-727.
11. Conn W (1997): Bioavailability of vitamin E. Eur J. Clin. Nutr. 51, S80-S85.
12. Esterbauer H & Jurgens G (1993): Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr. Opin. Lipidol. 4, 114-124.
13. Duthie GG, Arthur JR, Beattie JAG, Brown KM, Morrice PC, Robertson JD, Shortt CT, Walker KA & James WPT (1993): Cigarette smoking, antioxidants, lipid peroxidation, and coronary heart disease. Ann. N. Y. Acad. Sci. 686, 120-129.
14. Ferns GAA, Konneh, M & Anggard EE (1993): Vitamin E: the evidence for an anti-atherogenic role. Artery 20, 671-694.
15. Frei B, England L & Ames BN (1989): Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. 86, 6377-6381.
16. Frei B (1995): Cardiovascular disease and nutrient antioxidants: role of low density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr. 35, 83-98.
17. Gey KF, Puska P, Jordan P & Moser UK (1991): Inverse correlation between plasma vitamin E and mortality from ischaemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53, 326-334.
18. Gey KF (1995): Ten year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J Nutr. Biochem. 6, 206-236.
19. Gregory J, Foster K, Tyler H & Wiseman M (1990): The Dietary and Nutritional Survey of British Adults. London: HMSO, 123.
20. Halliwell B (1995): Oxidation of low density lipoproteins: questions of initiation propagation and the effects of antioxidants. Am. J. Clin. Nutr. 61, 670S-677S.
21. Hansen LG & Warwick WJ (1969): A fluorimetric micromethod for serum vitamins A and E. Am. J. Clin. Path. 51, 538-541.
22. Hong Kong Department of Health Annual Departmental Report (1997).
23. Janus ED for the Cardiovascular Risk Factor Prevalence Study Group (1997): Hong Kong Cardiovascular Risk Factor Prevalence Study 1996.
24. Jialal I & Devaraj S (1996): Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin. Chem. 42, 498-506.
25. Jialal I, Fuller CJ & Huet BA (1995): The effect of alpha tocopherol supplementation on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 15, 190-198.
26. Leung SSF, Ho S, Woo J, Lam TH & Janus ED (1997): Hong Kong Adult Dietary Survey, 1995.
27. Machlin LJ (1995): Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease. Crit. Rev. Food Sci. Nutr. 35, 41-50.
28. Maxwell SRJ & Lip GYH (1997): Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 44, 307-317.
29. Niki E (1987): Interaction of ascorbic acid and alpha tocopherol. Ann. N. Y. Acad. Sci. 498, 186-199.
30. Parfitt VJ, Rubba P, Bolton C, Marotta G & Mancini M (1994): A comparison of antioxidant status and free radical peroxidation of plasma lipoproteins in healthy young persons from Naples and Bristol. Eur. Heart J. 15, 871-876.
31. Rapola JM, Vitamo J, Haukka JK, Heinonen OP, Albanes D, Taylor PR, & Huttunen JK (1996): Effect of vitamin E and beta carotene on the incidence of angina pectoris. JAMA 275, 693-698.
32. Riemersma RA, Oliver M, Elton RA, Alfthan G, Vartianinen E, Salo M, Rubba P, Mancini M, Georgi H, Vuilleumier JP & Gey KF (1990): Plasma antioxidants and coronary heart disease: Vitamins C, E and selenium. Eur. J. Clin. Nutr. 44, 143-150.
33. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA & Willett WC (1993): Vitamin E consumption and risk of coronary heart disease in men. New Eng. J. Med. 328, 1450-1456.
34. Schultz M, Leist M, Petrzika M, Gassman B & Brigelius-Flohe R (1995): Novel urinary metabolite of alpha tocopherol, 2,5,7,8, tetra methyl-2-(2′-carboxyethyl)-6-hydroxy-chroman), as an indicator of an adequate vitamin E supply? Am. J. Clin. Nutr. 62, 1527S-1534S.
35. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B & Willett WC (1993): Vitamin E consumption and the risk of coronary heart disease in women. New Engl. J. Med. 328, 1444-1449.
36. Stephens NG, Parsons A, Schofield PM, Cheeseman K & Mitchinson MJ (1996): Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786.
37. Succari M, Garric B, Ponteziere C, Miocque M & Cals MJ (1991): Influence of sex and age on vitamin A and E status. Age and Ageing 20, 413-416.
38. Thomas S. 38 R, Neuzil J, Mohr D & Stocker R (1995): Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein. Am. J. Clin. Nutr. 62, 1357S-1364S.
39. Thumham DI, Davies JA, Crump BJ, Situnayake RD & Davis M (1986): The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin F. status. Ann. Clin. Biochem. 23, 514-517.
40. Traber M (1994): Determinants of plasma vitamin E concentrations. Free. Rad. Biol. Med. 16, 229-239.
41. Traber MG & Packer L (1995): Vitamin E: beyond antioxidant function. Am. J. Clin. Nutr. 62, 1501S-1509S.
42. Vandewoude MFJ & Vandewoude MG (1987): Vitamin E status in a normal population: the influence of age. J. Am. Coll. Nulr. 6, 307-311.
43. Weber P, Bendich A & Machlin LJ (1997): Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 13, 450-460.
44. Winklehofer-Roob BM. van't Hof MA & Shmerling DH (1997): Reference values for plasma concentrations of vitamin E and A and carotenoids in a Swiss population from infancy to adulthood, adjusted for seasonal influence. Clin. Chem. 43, 146-153.
45. World Health Organisation (1995): World Health Statistics Annual. Geneva: WHO.